Ameer B, Salter F J
Am J Hosp Pharm. 1979 Dec;36(12):1683-91.
The chemistry, pharmacology, uses, side effects, pharmacokinetics and dosage of butorphanol tartrate, a narcotic analgesic with antagonist properties, are reviewed. When administered intramuscularly or intravenously, butorphanol tartrate appears to be as effective for relieving moderate to severe pain as are pentazocine, meperidine and morphine. Butorphanol produces sedation more commonly and, at therapeutic dosages, depresses respiration as much as these other narcotic analgesics. A limited number of long-term clinical studies suggest a lower physical dependence liability with butorphanol than with other narcotic analgesics. Butorphanol is more expensive than morphine and, for most patients, offers no significant advantages over morphine for short-term use. Because butorphanol's cardiovascular effects are not completely understood, morphine also remains the drug of choice for pain associated with myocardial infarction.
本文综述了酒石酸布托啡诺的化学性质、药理学特性、用途、副作用、药代动力学及剂量。酒石酸布托啡诺是一种具有拮抗特性的麻醉性镇痛药。肌内注射或静脉注射时,酒石酸布托啡诺在缓解中度至重度疼痛方面似乎与喷他佐辛、哌替啶和吗啡一样有效。布托啡诺更常引起镇静作用,且在治疗剂量下,与其他麻醉性镇痛药一样会抑制呼吸。有限的长期临床研究表明,与其他麻醉性镇痛药相比,布托啡诺产生身体依赖性的可能性较低。布托啡诺比吗啡更昂贵,对大多数患者而言,短期使用时与吗啡相比并无显著优势。由于布托啡诺对心血管的影响尚未完全明确,因此吗啡仍是心肌梗死相关疼痛的首选药物。